NUTRITION ADVANCING LIFE
Live / Registered — Cancelled — Section 71 (as of 14 Aug 2026)
What this means for you
Registered since 28 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79256120
- Registration number
- 5969827
- Mark type
- Stylized text
- Filed
- 26 Feb 2019
- Published for opposition
- 12 Nov 2019
- Registered
- 28 Jan 2020
- Attorney of record
- Michelle P. Ciotola
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; gastro-intestinal treatment preparations; medicines for human use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; medicines for intestinal disorders; pharmaceutical products, namely pills, capsules, tablets, caplets, liquid drops, sachets and beverages for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemical preparations for pharmaceutical purposes for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; chemicals for pharmaceutical use for the treatment, prevention and management of immune disorders and inflammatory diseases of the gastrointestinal system, gastro-intestinal diseases and intestinal diseases in babies and infants; diagnostic preparations for medical purposes; pharmaceutical preparations, herbal supplements and veterinary preparations all for the prevention, treatment and management of immune disorders and inflammatory diseases of the gastrointestinal system
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely pharmaceutical research and new product development, research and design thereto; scientific and technological research services in the pharmaceutical, biotechnology, biochemistry and chemistry fields; scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry research and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; services for assessing the efficacy and safety of pharmaceuticals, namely pharmaceutical product evaluation and testing and inspection of pharmaceuticals; preparation of scientific reports relating to scientific research; analytical laboratory services, namely chemical and medical laboratories; laboratory research and analysis in the pharmaceutical, biotechnology, biochemistry and chemistry fields; development of products; development of new products; advisory services relating to scientific research; scientific consultancy and information services relating to the aforementioned services
Owner
Prosecution history
- 14 Aug 2026 — CANCELLED SECTION 71
- 28 Jan 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 24 Sept 2022 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 29 May 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 07 May 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 May 2020 — FINAL DISPOSITION PROCESSED
- 28 Apr 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 28 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 12 Nov 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Nov 2019 — PUBLISHED FOR OPPOSITION
- 09 Nov 2019 — NOTIFICATION PROCESSED BY IB
- 23 Oct 2019 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 23 Oct 2019 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 23 Oct 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2019 — ASSIGNED TO LIE